C59H84N18O14
1269.4 g/mol
Pharmaceutical IntermediateWarning
(Ser(tBu)6,Azagly10)-LHRH
CAS184686-52-0
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate
(Ser(tBu)6,Azagly10)-LHRH is a peptide analog intermediate used in the synthesis of LHRH (luteinizing hormone-releasing hormone) analogs. It features a tert-butyl-protected serine at position 6 and an azaglycine residue at position 10, and its structure includes multiple amide bonds and aromatic rings.
Pharmaceutical intermediate for LHRH peptide analog manufacturingReagent for peptide synthesis research
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 184686-52-0
Related Compounds
ReferenceSame Category
1-Benzyl-3-aminopyrrolidine
CAS18471-40-4
pharmaceutical intermediate
ReferenceSame Category
Isopropyl 2-chloro-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate
CAS1847463-39-1
pharmaceutical intermediate
ReferenceSame Category
4-Amino-1,1,1-trifluoro-3-buten-2-one
CAS184848-89-3
pharmaceutical intermediate
ReferenceSame Category
4-Phenylbutyryl chloride
CAS18496-54-3
pharmaceutical intermediate
Referencestereoisomer of
Goserelin Impurity G
CAS1926163-37-2
pharmaceutical raw material
Referencestereoisomer of
(D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH
CAS1926163-38-3
pharmaceutical raw material
Referencestereoisomer of
(2S)-1-((2S)-2-((2S)-2-((2R)-3-(tert-butoxy)-2-((2S)-2-((2R)-3-hydroxy-2-((2S)-2-((2S)-3-(1H-imidazol-5-yl)-2-(((2S)-5-oxopyrrolidin-2-yl)formamido)propanamido)-3-(1H-indol-3-yl)propanamido)propanamido)-3-(4-hydroxyphenyl)propanamido)propanamido)-4-methylpentanamido)-5-carbamimidamidopentanoyl)-N-(carbamoylamino)pyrrolidine-2-carboxamide
CAS1926163-39-4
pharmaceutical raw material
Referencestereoisomer of
Goserelin
CAS65807-02-5
pharmaceutical raw material
Safety Reference
Warning
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
InChIKey
BLCLNMBMMGCOAS-DXYQMANYSA-N
SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6
Synonyms (8)
- Goserelin EP Impurity B
- (Ser(tBu)6,Azagly10)-LHRH
- GOSERELIN IMPURITY B